Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old
- PMID: 30619907
- PMCID: PMC6306566
- DOI: 10.1093/ofid/ofy316
Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old
Abstract
Background: The epidemiology and burden of respiratory syncytial virus (RSV) illness are not well defined in older adults.
Methods: Adults ≥60 years old seeking outpatient care for acute respiratory illness were recruited from 2004-2005 through 2015-2016 during the winter seasons. RSV was identified from respiratory swabs by multiplex polymerase chain reaction. Clinical characteristics and outcomes were ascertained by interview and medical record abstraction. The incidence of medically attended RSV was estimated for each seasonal cohort.
Results: RSV was identified in 243 (11%) of 2257 enrollments (241 of 1832 individuals), including 121 RSV type A and 122 RSV type B. The RSV clinical outcome was serious in 47 (19%), moderate in 155 (64%), and mild in 41 (17%). Serious outcomes included hospital admission (n = 29), emergency department visit (n = 13), and pneumonia (n = 23) and were associated with lower respiratory tract symptoms during the enrollment visit. Moderate outcomes included receipt of a new antibiotic prescription (n = 144; 59%), bronchodilator/nebulizer (n = 45; 19%), or systemic corticosteroids (n = 28; 12%). The relative risk of a serious outcome was significantly increased in persons aged ≥75 years (vs 60-64 years) and in those with chronic obstructive pulmonary disease or congestive heart failure. The average seasonal incidence was 139 cases/10 000, and it was significantly higher in persons with cardiopulmonary disease compared with others (rate ratio, 1.89; 95% confidence interval, 1.44-2.48).
Conclusions: RSV causes substantial outpatient illness with lower respiratory tract involvement. Serious outcomes are common in older patients and those with cardiopulmonary disease.
Keywords: RSV; adult; epidemiology; incidence; outcomes.
Figures
Similar articles
-
The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis.Epidemiol Infect. 2020 Feb 13;148:e48. doi: 10.1017/S0950268820000400. Epidemiol Infect. 2020. PMID: 32052719 Free PMC article.
-
Medically attended respiratory syncytial virus infections in adults aged ≥ 50 years: clinical characteristics and outcomes.Clin Infect Dis. 2014 Feb;58(3):342-9. doi: 10.1093/cid/cit767. Epub 2013 Nov 21. Clin Infect Dis. 2014. PMID: 24265361 Free PMC article.
-
Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6-59 Months Old During Four Seasons.Open Forum Infect Dis. 2016 Apr 21;3(2):ofw081. doi: 10.1093/ofid/ofw081. eCollection 2016 Apr. Open Forum Infect Dis. 2016. PMID: 27419158 Free PMC article.
-
Seasonal incidence of medically attended respiratory syncytial virus infection in a community cohort of adults ≥50 years old.PLoS One. 2014 Jul 15;9(7):e102586. doi: 10.1371/journal.pone.0102586. eCollection 2014. PLoS One. 2014. PMID: 25025344 Free PMC article.
-
Respiratory syncytial virus infection in adults.Semin Respir Crit Care Med. 2007 Apr;28(2):171-81. doi: 10.1055/s-2007-976489. Semin Respir Crit Care Med. 2007. PMID: 17458771 Review.
Cited by
-
Severity of RSV infection in Southern European elderly patients during two consecutive winter seasons (2017-2018).J Med Virol. 2021 Aug;93(8):5152-5157. doi: 10.1002/jmv.26938. Epub 2021 Mar 23. J Med Virol. 2021. PMID: 33704814 Free PMC article.
-
Estimating the burden of adult hospitalized RSV infection using local and state data - methodology.Hum Vaccin Immunother. 2022 Dec 31;18(1):1958610. doi: 10.1080/21645515.2021.1958610. Hum Vaccin Immunother. 2022. PMID: 35271432 Free PMC article.
-
The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis.Epidemiol Infect. 2020 Feb 13;148:e48. doi: 10.1017/S0950268820000400. Epidemiol Infect. 2020. PMID: 32052719 Free PMC article.
-
Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study.Open Forum Infect Dis. 2023 Mar 1;10(4):ofad111. doi: 10.1093/ofid/ofad111. eCollection 2023 Apr. Open Forum Infect Dis. 2023. PMID: 37065988 Free PMC article.
-
Estimation of the Number of Respiratory Syncytial Virus-Associated Hospitalizations in Adults in the European Union.J Infect Dis. 2023 Nov 28;228(11):1539-1548. doi: 10.1093/infdis/jiad189. J Infect Dis. 2023. PMID: 37246742 Free PMC article.
References
-
- McCracken JP, Prill MM, Arvelo W, et al. . Respiratory syncytial virus infection in Guatemala, 2007–2012. J Infect Dis 2013; 208(Suppl 3):S197–206. - PubMed
-
- Morales F, Calder MA, Inglis JM, et al. . A study of respiratory infections in the elderly to assess the role of respiratory syncytial virus. J Infect 1983; 7:236–47. - PubMed
LinkOut - more resources
Full Text Sources